North America Contraceptives Market Size (2024 - 2029)

The North America contraceptives market is experiencing growth driven by an increase in the use of contraceptive devices due to rising unwanted pregnancies in the region. Government initiatives aimed at raising awareness about contraceptives and family planning are further supporting the expansion of this market, as these initiatives align with the fundamental right to privacy regarding contraceptive use. However, concerns about the side effects of contraceptive devices are posing challenges to the market's growth.

Market Size of North America Contraceptives Industry

North America Contraceptives Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 5.90 %

Major Players

North America Contraceptives Market Major Players

*Disclaimer: Major Players sorted in no particular order

North America Contraceptives Market Analysis

The number of unwanted pregnancies is found increasing in the North American region, and it is a matter of serious concern all around the world. The increase in unwanted pregnancies has thus increased the usage of contraceptive devices in North America. Thus all these factors have been primary drivers for the growth of this market.

Moreover, initiatives by the government to raise awareness regarding contraceptives and family planning have also helped the growth of the market. As the right to obtain and use contraceptives is part of the fundamental right to privacy guaranteed by the United States Constitution. Thus, government initiatives are promoting the use of contraceptives to avoid unnecessary births. However, the side effects of contraceptive devices have been restraining market growth.

North America Contraceptives Industry Segmentation

As per the scope of the report, contraceptive drugs and devices are used for birth control. Contraception is more commonly known as fertility, and birth control is described as the method used to avoid pregnancy. These devices and drugs function by changing the mechanism of ovulation or by acting as a physical barrier between the sperm and ovum. The proper use of contraceptives, such as female and male condoms, also prevents the spread of sexually transmitted diseases.

By Products
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUDs
Other Devices
By Gender
Male
Female
Geography
North America
United States
Canada
Mexico
Need A Different Region Or Segment?
Customize Now

North America Contraceptives Market Size Summary

The North American contraceptives market is experiencing significant growth driven by the rising incidence of unwanted pregnancies, which has heightened the demand for contraceptive devices. Government initiatives aimed at raising awareness about contraceptives and family planning have further bolstered market expansion. These efforts are supported by the constitutional right to privacy in the United States, which includes access to contraceptives, thereby promoting their use to prevent unintended births. Despite these positive trends, the market faces challenges due to the side effects associated with contraceptive devices, which can hinder growth.

The use of condoms, a key contraceptive method, is on the rise in both developing and developed countries within North America, such as Mexico and the United States. This increase is partly attributed to the need to reduce the risk of sexually transmitted infections (STIs), which, although decreasing, remain prevalent in certain areas. The well-structured healthcare systems in the United States and Canada, along with supportive research and development policies, have attracted numerous global market players, enhancing the market's growth potential. Companies like Bayer AG, Merck & Co. Inc., Teva Pharmaceuticals Ltd, Pfizer, and Agile Therapeutics are prominent in the region, contributing to the market's expansion.

Explore More

North America Contraceptives Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Rate of Unintended Pregnancies

      2. 1.2.2 Rise in Government Initiatives

    3. 1.3 Market Restraints

      1. 1.3.1 Side Effects Associated with the Use of Contraceptive Drugs and Devices

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Products

      1. 2.1.1 By Drugs

        1. 2.1.1.1 Oral Contraceptives

        2. 2.1.1.2 Topical Contraceptives

        3. 2.1.1.3 Contraceptive Injectable

      2. 2.1.2 By Device

        1. 2.1.2.1 Condoms

        2. 2.1.2.2 Diaphragms

        3. 2.1.2.3 Cervical Caps

        4. 2.1.2.4 Sponges

        5. 2.1.2.5 Vaginal Rings

        6. 2.1.2.6 IUDs

        7. 2.1.2.7 Other Devices

    2. 2.2 By Gender

      1. 2.2.1 Male

      2. 2.2.2 Female

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

North America Contraceptives Market Size FAQs

The North America Contraceptives Market is projected to register a CAGR of 5.90% during the forecast period (2024-2029)

Bayer AG, Merck & Co. Inc., Teva Pharmaceuticals Ltd, Pfizer and Agile Therapeutics are the major companies operating in the North America Contraceptives Market.

North America Contraceptives Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)